13F-HR filed by Svennilson Peter
Svennilson Peter filed this 13F-HR for the quarter ended 2020-06-30, filed 2020-08-12, with 7 holding rows worth $1,195,756,000.
- Accession
- 0000950123-20-008388
- Filer
- CIK 1606074
- Filed
- 2020-08-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2020
A holdings report, 11 entries on the cover page, a total value of $1,195,756,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,195,756,000 with VALUE read as thousands by filing date, 13F file number 028-16412. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerThe Column Group II, LP 028-19198
- included managerThe Column Group II GP, LP 028-19199
- included managerDavid Goeddel 028-16413
- included managerThe Column Group, LP 028-16410
- included managerThe Column Group GP, LP 028-16411
- included managerPonoi Capital, LP 028-19917
- included managerPonoi Management, LLC 028-19916
- included managerTim Kutzkey 028-19915
- included managerPonoi Capital II, LP 028-19919
- included managerPonoi II Management, LLC 028-19918
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NGM BIOPHARMACEUTICALS INC | 62921N105 | COM | 17,706,978 | $349,536,000 | thousands by filing date | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 7,977,384 | $251,846,000 | thousands by filing date | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 6,777,151 | $196,673,000 | thousands by filing date | |
| CONSTELLATION PHARMACEUTICALS INC. | 210373106 | Common Stock | 6,051,376 | $181,844,000 | thousands by filing date | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 4,768,181 | $160,831,000 | thousands by filing date | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 1,767,676 | $43,732,000 | thousands by filing date | |
| GRITSTONE BIO INC | 39868T105 | COM | 1,700,945 | $11,294,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-20-008388 | this filing | 2020-08-12 | acceptance time not in the bulk data set |